Rosiglitazone alleviates lipopolysaccharide‑induced inflammation in RAW264.7 cells via inhibition of NF‑κB and in a PPARγ‑dependent mannerJingping Zhou, Ligang Chen|Experimental and Therapeutic Medicine|2021Cited by 26